CHIPPING CAMPDEN SURGERY
BACK ENDS, CHIPPING CAMPDEN
COPD 13
The percentage of patients with COPD who have had a review, undertaken by a healthcare professional, including an assessment of breathlessness using the MRC dyspnoea score in the preceding 15 months.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| COPD 13 | 2010 | 36 | 38 | 94.7% | |
| COPD 13 | 2011 | 40 | 40 | 100.0% | |
| COPD 13 | 2012 | 36 | 39 | 92.3% | |
| COPD 13 | 2013 | 36 | 39 | 92.3% | |
| COPD003 | 2014 | 33 | 36 | 91.7% | |
| COPD003 | 2015 | 48 | 51 | 94.1% | |
| COPD003 | 2016 | 51 | 51 | 100.0% | |
| COPD003 | 2017 | 58 | 60 | 96.7% | |
| COPD003 | 2018 | 55 | 59 | 93.2% | |
| COPD003 | 2019 | 61 | 61 | 100.0% | |
| COPD003 | 2020 | 75 | 76 | 98.7% | |
| COPD010 | 2021 | 74 | 78 | 94.9% | |
| COPD010 | 2022 | 68 | 72 | 94.4% | |
| COPD010 | 2023 | 65 | 66 | 98.5% |
